Skip to content
lifestyle.friendhood.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Spago Nanomedical
Notice of Extraordinary General Meeting in Spago Nanomedical AB (PUBL)
October 22, 2026
The Board of Directors of Spago Nanomedical Has Resolved, Subject to the Approval of the General Meeting, to Apply for Delisting From the NASDAQ First North Growth Market
October 22, 2026
Bulletin from the Extraordinary General Meeting of Spago Nanomedical AB
October 22, 2026
Spago Nanomedical to Participate in Several International Industry Conferences During Autumn 2026
September 29, 2026
Notice Of Extraordinary General Meeting in Spago Nanomedical AB (PUBL)
September 21, 2026
Spago Nanomedical Interim Report January-June 2026
August 20, 2026
Bulletin from the 2026 Annual General Meeting of Spago Nanomedical AB
June 10, 2026
Notice To Annual General Meeting of Spago Nanomedical AB (PUBL)
May 11, 2026
Spago Nanomedical Interim Report January-March 2026
May 7, 2026
Spago Nanomedical’s Phase I/IIa study Tumorad-01 Meets a Primary Endpoint and Provides Further Visible Tumor Uptake
May 6, 2026